Skip to content

Statistics on 2018/19 Vaccination Programmes / Schemes

Statistics on 2018/19 Vaccination Programmes / Schemes

2019-06-17

Statistics on 2018/19 Vaccination Programmes/Schemes (as at 9 June 2019 day end)

Government Vaccination Programme

Total no. of doses administered to target groups

Categories

Seasonal Influenza Vaccine

Pneumococcal Vaccine

No. of doses administered

491 000

93 000


Vaccination Subsidy Scheme

Total no. of doses administered* to target groups

Categories

Seasonal Influenza Vaccine

Pneumococcal Vaccine

No. of doses administered 583 000# 30 000

* Based on the no. of claim reimbursement submitted by private doctors through eHealth System (Subsidies)

# Including no. of doses administered to children under the Enhanced VSS Outreach Vaccination at primary schools, kindergartens, kindergarten-cum-child care centres and child care centres, which has been enhanced in 2018-19


Statistics on School Outreach Vaccination Pilot Programme

Total no. of doses administered to target groups
Category Seasonal Influenza Vaccine
No. of doses administered 121 000

Background Information on Adverse Events following seasonal influenza vaccination

1. The 2018/19 quadrivalent seasonal influenza vaccine contains the following:
  • an A/Michigan/45/2015 (H1N1)pdm09-like virus
  • an A/Singapore/INFIMH-16-0019/2016 (H3N2)-like virus
  • a B/Colorado/06/2017-like virus
  • a B/Phuket/3073/2013-like virus

If trivalent influenza vaccine is being used, the influenza B component shall contain a B/Colorado/06/2017-like virus.

2. Seasonal influenza vaccine is very safe and usually well tolerated apart from occasional soreness, redness or swelling at the injection site (inactivated vaccine).  Some recipients may experience fever, muscle and joint pains, and tiredness beginning 6 to 12 hours after vaccination and lasting up to two days.

3. An adverse event is a health problem that is reported after someone gets vaccinated. It may or may not have been caused by the vaccine.  Some of these events may occur by chance during the post-vaccination period and are unrelated to vaccination. Report of adverse event does not mean that a vaccine caused the event.

Number of GBS (within the period of 5 days and 6 weeks after vaccination) and other serious neurological adverse events reported among vaccinated person in 2018/19 season (as of 12 noon, 10 June 2019):

Guillain-Barré Syndrome
Other serious neurological adverse events
0
1

For the number of newly admitted GBS cases in Hong Kong, please click here.